MedTrace Logo

Modifying Virtual Reality Analgesia With Low-Dose Pain Medication

NCT01840774 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-04-26

No results posted yet for this study

Summary

The purpose of this study is to determine how pain relief is modified when the investigators combine the Virtual Reality based Snow World game with certain pain medications.

Conditions

  • Virtual Reality Therapy

Interventions

DRUG

Low-dose pain medication (Ketalar) and saline placebo

Sponsors & Collaborators

Principal Investigators

  • Samuel Sharar, MD · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01840774 on ClinicalTrials.gov